Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions.
2022-06-30
عنوان الدراسة
Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions.
داعم الدراسة
MEDIS Laboratories
دواء الدراسة
Tacrolimus/ Prograf
رقم بروتوكول الدراسة
19-2017
حالة الدراسة
Ongoing
موقع الدراسة
Saudi Ajal
مرحلة الدراسة
1
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。